Main Page
Deanship
The Dean
Dean's Word
Curriculum Vitae
Contact the Dean
Vision and Mission
Organizational Structure
Vice- Deanship
Vice- Dean
KAU Graduate Studies
Research Services & Courses
Research Services Unit
Important Research for Society
Deanship's Services
FAQs
Research
Staff Directory
Files
Favorite Websites
Deanship Access Map
Graduate Studies Awards
Deanship's Staff
Staff Directory
Files
Researches
Contact us
عربي
English
About
Admission
Academic
Research and Innovations
University Life
E-Services
Search
Deanship of Graduate Studies
Document Details
Document Type
:
Thesis
Document Title
:
POTENTIAL EFFECT OF ELETTERIA CARDAMOM EXTRACT ON ENHANCEMENT OF SORFENIB- INDUCED APOPTOSIS IN HEPG2 CELLS.
التأثير المحتمل لمستخلص الهيل في تعزيز موت الخلايا المبرمج الناتج عن السورفينيب في خلايا HepG2.
Subject
:
Faculty of Home Economics
Document Language
:
Arabic
Abstract
:
The prognosis for liver cancer is very poor; globally it is the second most common cause of death. It can treat with sorafenib, but its use is limited due to its toxicity and adverse reactions. One approach to overcome this toxicity is to use lower doses of sorafenib in combination with other complementary agents. Cardamom seeds are one of the most common ingredients of Indian and Chinese traditional medicine, and different studies have suggested that cardamom extract can display anti-cancer activities. Aim: this study aimed to investigate the efficiency of Elettaria Cardamom Aqueous Extract (ECE) on enhancement of Sorafenib-induced apoptosis in HepG2. Methods: Human liver cancer cells (HepG2) were subjected to increasing doses of single and combined treatments of Sorafenib and ECE. Cells were then harvested after 24 h and cell viability was examined by MTT Assay. Clonogenicity assays and Cell Migration Assay were also carried out. Reactive oxygen species (ROS) generation and mitochondrial membrane potential (MMP) level were determined by DCFH-DA and JC-1 dye, respectively. Finally, agarose gel electrophoresis and comet assays were performed to assess the DNA damage. Result: Combined treatment of ECE with Sorafenib suppressed the proliferation, colony formation and cell migration of HepG2 cells more than the Sorafenib did only. the half maximal inhibitory concentration (IC50), after 24h of incubation were 15 µM of Sorafenib and 9 and 7.3 µM of Sorafenib enhanced by 5 and 10 µg / 100 µl of ECE respectively. HepG2 treated cells displayed biochemical features of apoptotic cell death. The combined treatment increased the ROS production, reduced the level of MMP, increased Comet tail length and induced Deoxyribonucleic acid (DNA) fragmentation more than Sorafenib did alone. Conclusion: These findings demonstrate that ECE enhanced the sorafenib effect in HepG2 cells and suggest that the ECE may be a promising agent for reducing sorafenib side effects in HCC.
Supervisor
:
Prof. Amani Aliwi Al-rasheedi
Thesis Type
:
Master Thesis
Publishing Year
:
1440 AH
2019 AD
Added Date
:
Thursday, July 11, 2019
Researchers
Researcher Name (Arabic)
Researcher Name (English)
Researcher Type
Dr Grade
Email
حياة أحمد الغامدي
Al-Ghamdi, Hayat Ahmad
Researcher
Master
Files
File Name
Type
Description
44698.pdf
pdf
Back To Researches Page